Neogen Corporation Total Liabilities
Neogen Corporation (NEOG) had Total Liabilities of $1.25 billion as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-07-30
- 2026-05-31: Liabilities $1.25B.
- 2026-02-28: Liabilities $1.26B.
- 2025-11-30: Liabilities $1.26B.
- 2025-08-31: Liabilities $1.26B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-05-31 | $1.25B 10-K · filed 2026-07-30 | |
| 2026-02-28 | $1.26B 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $1.26B 10-Q · filed 2026-01-08 | |
| 2025-08-31 | $1.26B 10-Q · filed 2025-10-09 | |
| 2025-05-31 | $1.37B 10-K · filed 2026-07-30 | $1.37B 10-K · filed 2025-07-30 |
| 2025-02-28 | $1.38B 10-Q · filed 2025-04-09 | |
| 2024-11-30 | $1.39B 10-Q · filed 2025-01-15 | |
| 2024-08-31 | $1.37B 10-Q · filed 2024-10-10 | |
| 2024-05-31 | $1.40B 10-K · filed 2025-07-30 | |
| 2024-02-29 | $1.44B 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $1.45B 10-Q · filed 2024-01-09 | |
| 2023-08-31 | $1.41B 10-Q · filed 2023-10-10 | |
| 2023-05-31 | $1.42B 10-K · filed 2024-07-30 | |
| 2023-02-28 | $1.38B 10-Q · filed 2023-04-04 | |
| 2022-11-30 | $1.46B 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $93.61M 10-Q · filed 2022-09-30 | |
| 2022-05-31 | $105.56M 10-K · filed 2023-08-15 | |
| 2022-02-28 | $105.66M 10-Q · filed 2022-04-01 | |
| 2021-11-30 | $101.20M 10-Q · filed 2021-12-30 | |
| 2021-08-31 | $76.74M 10-Q · filed 2021-09-30 | |
| 2021-05-31 | $79.81M 10-K · filed 2022-07-27 | |
| 2021-02-28 | $72.53M 10-Q · filed 2021-03-31 | |
| 2020-11-30 | $68.23M 10-Q · filed 2020-12-29 | |
| 2020-08-31 | $70.05M 10-Q · filed 2020-09-30 | |
| 2020-05-31 | $72.00M 10-K · filed 2021-07-30 | |
| 2020-02-29 | $61.63M 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $59.67M 10-Q · filed 2019-12-27 | |
| 2019-08-31 | $60.84M 10-Q · filed 2019-09-26 | |
| 2019-05-31 | $57.84M 10-K · filed 2020-07-30 | |
| 2019-02-28 | $52.67M 10-Q · filed 2019-03-29 | |
| 2018-11-30 | $58.42M 10-Q · filed 2018-12-28 | |
| 2018-08-31 | $59.30M 10-Q · filed 2018-10-05 | |
| 2018-05-31 | $57.83M 10-K · filed 2019-07-30 | |
| 2018-02-28 | $53.67M 10-Q · filed 2018-03-29 | |
| 2017-11-30 | $60.38M 10-Q · filed 2018-01-05 | |
| 2017-08-31 | $60.08M 10-Q · filed 2017-09-29 | |
| 2017-05-31 | $56.65M 10-K · filed 2018-07-27 | |
| 2017-02-28 | $55.64M 10-Q · filed 2017-03-31 | |
| 2016-11-30 | $52.54M 10-Q · filed 2016-12-29 | |
| 2016-08-31 | $51.40M 10-Q · filed 2016-09-30 | |
| 2016-05-31 | $45.78M 10-K · filed 2017-07-28 | $47.55M 10-K · filed 2016-07-29 |
| 2016-02-29 | $44.37M 10-Q · filed 2016-03-31 | |
| 2015-11-30 | $47.88M 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $43.48M 10-Q · filed 2015-09-30 | |
| 2015-05-31 | $41.22M 10-K · filed 2016-07-29 | |
| 2015-02-28 | $41.72M 10-Q · filed 2015-04-01 | |
| 2014-11-30 | $39.13M 10-Q · filed 2014-12-30 | |
| 2014-08-31 | $38.80M 10-Q · filed 2014-09-30 | |
| 2014-05-31 | $39.00M 10-K · filed 2015-07-30 | |
| 2014-02-28 | $39.23M 10-Q · filed 2014-04-04 | |
| 2013-11-30 | $37.90M 10-Q · filed 2014-01-09 | |
| 2013-08-31 | $37.41M 10-Q · filed 2013-09-30 | |
| 2013-05-31 | $32.27M 10-K · filed 2014-07-30 | |
| 2013-02-28 | $35.33M 10-Q · filed 2013-03-28 | |
| 2012-11-30 | $31.96M 10-Q · filed 2012-12-28 | |
| 2012-08-31 | $31.58M 10-Q · filed 2012-09-28 | |
| 2012-05-31 | $32.55M 10-K · filed 2013-07-30 | |
| 2012-02-29 | $30.36M 10-Q · filed 2012-03-30 | |
| 2011-11-30 | $31.19M 10-Q · filed 2011-12-30 | |
| 2011-08-31 | $31.06M 10-Q · filed 2011-09-30 | |
| 2011-05-31 | $30.68M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |